CANF logo

Can-Fite BioPharma Ltd.

CANF
Healthcare|Biotechnology|IL
$1.62
+0.02 (+1.25%)
Tangible Book / Share
$2.62
Cash / Share
$3.80

Ownership Breakdown

95.1%
Float
1.3M
Shares Outstanding
121.8M
Float Shares

Major Holders (3)

Combined: 14.1%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Steven BoydHC, IN4.99%440,422Feb 14, 202513D/G
Armistice Capital, LLCIA, OO4.99%440,422Feb 14, 202513D/G
Orca Capital AGCorporation4.10%157,382,700Apr 23, 202513D/G

Insider Trades (13)

Last 4 quarters: 0 acquired · 0 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Farbstein MottiCEO, CFO and COOJun 4, 2026AWARD24,000$2.04$49.0KForm 4
Fishman Pninadirector, officer: Chief Scientific OfficerJun 4, 2026AWARD24,000$2.04$49.0KForm 4
Tamir IlandirectorApr 25, 2026OTHER16,000$2.25$36.0KForm 4
Regev GuydirectorMar 18, 2026OTHER0——Form 4
Regev GuydirectorFeb 8, 2017OTHER16$2826.14$45.2KForm 4
Regev GuydirectorJun 15, 2020OTHER200$241.47$48.3KForm 4
Regev GuydirectorAug 1, 2023OTHER2,166$25.21$54.6KForm 4
Regev GuydirectorAug 7, 2024OTHER2,166$26.56$57.5KForm 4
Regev GuydirectorApr 25, 2026OTHER16,000$2.18$34.9KForm 4
Bornstein YosephdirectorJun 22, 2021OTHER200$241.47$48.3KForm 4
Bornstein YosephdirectorAug 1, 2023OTHER2,166$25.21$54.6KForm 4
Bornstein YosephdirectorAug 7, 2024OTHER2,166$26.56$57.5KForm 4
Bornstein YosephdirectorApr 25, 2026OTHER16,000$2.18$34.9KForm 4